Last week, readers were most interested in a story about a new respiratory test launched by Roche leveraging a new PCR technology.

Roche AG’s new test using its temperature-activated generation of signal technology is the next step in PCR evolution, Igor Kozlov, head of Reagent Research and Design at Roche Diagnostics Solutions, ...

The Temperature-Activated Generation of Signal (TAGS) technology was developed by Roche for its high-throughput PCR-based instruments.

The TAGS technology has PCR testing capabilities on high-throughput systems such as the cobas 5800, 6800, and 8800 models.

Roche’s TAGS technology allows tests to simultaneously detect multiple respiratory viruses, including influenza A and B, RSV ...

The TAGS technology – or Temperature-Activated Generation of Signal to give it its full name – allows up to 15 diagnostic ...

Roche is rolling out what it describes as a new type of infectious disease diagnostic in Europe, with a single test capable ...

Swiss drug major Roche Group (RHHBY) announced Tuesday the launch of the cobas Respiratory flex test, the first to use Roche's novel ...

The global digital PCR (dPCR) and real-time PCR (qPCR) market is set to expand significantly, with projections indicating ...

Roche introduces cobas Respiratory flex test to use its TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses: Basel Wednesday, September 25, 2024, ...

Basel: Roche announced today the launch of the cobas Respiratory flex test, the first to use Roche's novel and proprietary ...

New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a ...